AR073871A1 - Intermediario de fulvestran - Google Patents
Intermediario de fulvestranInfo
- Publication number
- AR073871A1 AR073871A1 ARP090103963A ARP090103963A AR073871A1 AR 073871 A1 AR073871 A1 AR 073871A1 AR P090103963 A ARP090103963 A AR P090103963A AR P090103963 A ARP090103963 A AR P090103963A AR 073871 A1 AR073871 A1 AR 073871A1
- Authority
- AR
- Argentina
- Prior art keywords
- fulvestran
- intermediary
- preparation
- acetyl
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Se relaciona con un compuesto de la formula (1) en donde R1 representa H o un grupo acetilo y R2 representa un grupo metilo, acetilo o bencilo; con su preparacion y con su uso en la preparacion de fulvestrant.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10562608P | 2008-10-15 | 2008-10-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR073871A1 true AR073871A1 (es) | 2010-12-09 |
Family
ID=41664932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090103963A AR073871A1 (es) | 2008-10-15 | 2009-10-15 | Intermediario de fulvestran |
Country Status (5)
Country | Link |
---|---|
US (1) | US20100105934A1 (es) |
EP (1) | EP2350111A1 (es) |
CN (1) | CN102227441A (es) |
AR (1) | AR073871A1 (es) |
WO (1) | WO2010043404A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016027000A (ja) * | 2012-10-09 | 2016-02-18 | 学校法人早稲田大学 | ステロイド化合物及びこれを含有する医薬 |
EP2909224B1 (en) | 2012-10-22 | 2020-03-18 | Intas Pharmaceuticals Limited | An improved process for the preparation of fulvestrant |
WO2015181116A1 (en) | 2014-05-26 | 2015-12-03 | Crystal Pharma, S.A.U. | Process and intermediades for the preparation of 7-alkylated steroids |
CN107286213A (zh) * | 2016-03-31 | 2017-10-24 | 杭州共泽医药科技有限公司 | 一种氟维司群中间体的制备方法 |
MX2020002649A (es) | 2017-09-11 | 2020-09-25 | Atossa Therapeutics Inc | Metodos para hacer y usar endoxifeno. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8327256D0 (en) * | 1983-10-12 | 1983-11-16 | Ici Plc | Steroid derivatives |
DE4218743C2 (de) * | 1992-06-04 | 2001-10-25 | Schering Ag | Verfahren zur Herstellung C(7)-substituierter Estra-1,3,5(10)-triene sowie neue Ausgangsprodukte für dieses Verfahren |
TW548277B (en) * | 1999-07-16 | 2003-08-21 | Akzo Nobel Nv | Orally active androgens |
GB0123961D0 (en) * | 2001-10-05 | 2001-11-28 | Astrazeneca Ab | Process and intermediates |
-
2009
- 2009-10-14 CN CN2009801471875A patent/CN102227441A/zh active Pending
- 2009-10-14 WO PCT/EP2009/007432 patent/WO2010043404A1/en active Application Filing
- 2009-10-14 EP EP09744062A patent/EP2350111A1/en not_active Withdrawn
- 2009-10-15 AR ARP090103963A patent/AR073871A1/es unknown
- 2009-10-15 US US12/579,478 patent/US20100105934A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN102227441A (zh) | 2011-10-26 |
WO2010043404A1 (en) | 2010-04-22 |
US20100105934A1 (en) | 2010-04-29 |
EP2350111A1 (en) | 2011-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2044028T3 (da) | Cyanoisoquinolinforbindelser til stabilisering af den hypoxiinducerende faktor (HIF) | |
NO20071880L (no) | Diagnostic Compounds | |
BRPI0607279A2 (pt) | composição compatìvel com fertilizante | |
CY1109911T1 (el) | Πυρρολοβενζοδιαζεπινες | |
AR083234A1 (es) | Composicion pesticida y su uso | |
DK1893587T3 (da) | Fremgangsmåde til fremstilling af dihydroquinazoliner | |
ECSP056111A (es) | Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica | |
NL1033650A1 (nl) | Antilichamen tegen myostatine. | |
BRPI0814593A2 (pt) | Composto, composição farmacêutica que o contém e uso do composto. | |
CR10847A (es) | Compuesto heteromonociclico y uso del mismo | |
EA201070519A1 (ru) | Соединения тропана | |
BRPI0813341A2 (pt) | " uso de compostos, composições curáveis, e, uso de composições curáveis ". | |
EA201171246A1 (ru) | Содержащая трегалулозу композиция, ее получение и применение | |
RS52255B (en) | NALMEFEN HYDROCHLORIDE DIHYDRATE | |
BRPI0913833A2 (pt) | uso de corantes ácidos | |
ATE485261T1 (de) | Salicylsäurederivate | |
BRPI0916480A2 (pt) | composto de fórmula geral (i) e uso de pelo menos um composto | |
FR2880904B1 (fr) | Perfectionnements au mode de construction par elements standardises | |
BRPI0813587A2 (pt) | Composto, uso do mesmo, e, composição farmacêutica | |
AR073871A1 (es) | Intermediario de fulvestran | |
BRPI0911772A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
EA200900780A1 (ru) | Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства | |
DE602006006016D1 (de) | Herstellung von Epoxidhärter enthaltenden wässrigen Zusammensetzungen | |
PA8668901A1 (es) | Derivados de tetrahidronaftalina, procedimientos para su preparacion y su uso como antiinflamatorios | |
ECSP109874A (es) | Nuevos compuestos 892 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |